Rothia bacteremia: A 10-year experience at Mayo Clinic, Rochester, Minnesota

Journal of Clinical Microbiology

Volumn 52, Issue 9, 2014, Pages 3184-3189

  Ramanan, Poornima ^a   Barreto, Jason N ^a   Osmon, Douglas R ^a   Tosh, Pritish K ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; BACTEREMIA; BLOOD; COHORT ANALYSIS; COMPLICATION; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; ISOLATION AND PURIFICATION; LEUKEMIA; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MICROCOCCACEAE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL; UNITED STATES; YOUNG ADULT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; COHORT STUDIES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LEUKEMIA; MALE; MICROBIAL SENSITIVITY TESTS; MICROCOCCACEAE; MIDDLE AGED; MINNESOTA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84906862040     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01270-14     Document Type: Article

References (18)

1. Trivedi MN, Malhotra P. Rothia prosthetic knee joint infection. J. Microbiol. Immunol. Infect. in press. http://dx.doi.org/10.1016/j.jmii.2012.12. 001.
2. Vaccher S, Cordiali R, Osimani P, Manso E, de Benedictis FM. 2007. Bacteremia caused by Rothia mucilaginosa in a patient with Shwachman-Diamond syndrome. Infection 35:209-210. http://dx.doi.org/10.1007/s15010-007-6284-8. (Pubitemid 46932333)
3. Bruminhent J, Tokarczyk MJ, Jungkind D, Desimone JA, Jr. 2013. Rothia mucilaginosa prosthetic device infections: a case of prosthetic valve endocarditis. J. Clin. Microbiol. 51:1629-1632. http://dx.doi.org/10.1128/JCM. 03173-12.
4. Lee AB, Harker-Murray P, Ferrieri P, Schleiss MR, Tolar J. 2008. Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation. Pediatr. Blood Cancer 50:673-676. http://dx.doi.org/10.1002/pbc.21286. (Pubitemid 351155856)
5. Keng TC, Ng KP, Tan LP, Chong YB, Wong CM, Lim SK. 2012. Rothia dentocariosa repeat and relapsing peritoneal dialysis-related peritonitis: a case report and literature review. Ren. Fail. 34:804-806. http://dx.doi.org/10. 3109/0886022X.2012.678208.
6. Cho EJ, Sung H, Park SJ, Kim MN, Lee SO. 2013. Rothia mucilaginosa pneumonia diagnosed by quantitative cultures and intracellular organisms of bronchoalveolar lavage in a lymphoma patient. Ann. Lab. Med. 33:145-149. http://dx.doi.org/10.3343/alm.2013.33.2.145.
7. Partner AM, Bhattacharya S, Scott RA, Stavrou P. 2006. Rothia genus endophthalmitis following penetrating injury in a child. Eye 20:502-503. http://dx.doi.org/10.1038/sj.eye.6701902.
8. McWhinney PH, Kibbler CC, Gillespie SH, Patel S, Morrison D, Hoffbrand AV, Prentice HG. 1992. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin. Infect. Dis. 14:641-646. http://dx.doi.org/10.1093/ clinids/14.3.641.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383. http://dx.doi.org/10.1016/0021-9681(87) 90171-8. (Pubitemid 17055592)
10. Kaufhold A, Reinert RR, Kern W. 1992. Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature. Infection 20:213-220. http://dx.doi.org/10.1007/BF02033062.
11. Ascher DP, Zbick C, White C, Fischer GW. 1991. Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev. Infect. Dis. 13: 1048-1052. http://dx.doi.org/10.1093/clinids/13.6.1048.
12. Henwick S, Koehler M, Patrick CC. 1993. Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children. Clin. Infect. Dis. 17:667-671. http://dx.doi.org/10.1093/clinids/17.4.667. (Pubitemid 23293376)
13. Fanourgiakis P, Georgala A, Vekemans M, Daneau D, Heymans C, Aoun M. 2003. Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute. Clin. Microbiol. Infect. 9:1068-1072. 14616756. http://dx.doi.org/10.1046/j.1469-0691.2003.00772.x.
14. Chavan RS, Pannaraj PS, Luna RA, Szabo S, Adesina A, Versalovic J, Krance RA, Kennedy-Nasser AA. 2013. Significant morbidity and mortality attributable to Rothia mucilaginosa infections in children with hematological malignancies or following hematopoietic stem cell transplantation. Pediatr. Hematol. Oncol. 30:445-454. http://dx.doi.org/10.3109/08880018.2013.783893.
15. Goldman M, Chaudhary UB, Greist A, Fausel CA. 1998. Central nervous system infections due to Stomatococcus mucilaginosus in immunocompromised hosts. Clin. Infect. Dis. 27:1241-1246. http://dx.doi.org/10.1086/515001. (Pubitemid 29242478)
16. Korsholm TL, Haahr V, Prag J. 2007. Eight cases of lower respiratory tract infection caused by Stomatococcus mucilaginosus. Scand. J. Infect. Dis. 39:913-917. http://dx.doi.org/10.1080/00365540701387064. (Pubitemid 47470784)
17. von Eiff C, Herrmann M, Peters G. 1995. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob. Agents Chemother. 39:268-270. http://dx.doi.org/10.1128/AAC.39.1.268.
18. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America. 2011. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 52:427-431. http://dx.doi.org/10.1093/cid/ciq147.